Remission and low disease activity (LDA) prevent damage accrual in systemic lupus erythematosus patients. Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

Manuel Ugarte-Gil*, JG Hanly, MB Urowitz, Caroline Gordon, SC Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, S Bernatsky, A. E Clarke, D. J Wallace, David Isenberg, A Rahman, JT Merrill, PR Fortin, DD Gladman, I. N Bruce, M. A Petri, Ellen Ginzler, MA Dooley, R Ramsey GoldmanS Manzi, Andreas Jonsen, Ronald van Vollenhoven, Cynthia Aranow, M Mackay, Guillermo Ruiz-Irastorza, S. S Lim, M Inanc, K. C Kalunian, S. Jacobsen, C Peschken, Diane L Kamen, Anca D Askanase, Bernado Pons-Estel, GS Alarcón

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Remission and low disease activity (LDA) prevent damage accrual in systemic lupus erythematosus patients. Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort'. Together they form a unique fingerprint.

Chemistry

Medicine & Life Sciences